Assessing the suitability of cell counting methods during different stages of a cell processing workflow using an ISO 20391-2 guided study design and analysis

Frontiers in Bioengineering and Biotechnology

Bioengineering and Biotechnology

Sumona Sarkar¹  Richard Snyder²  Colleen Richards²  Uma Lakshmipathy²  Jennifer Kandell² 

[1] National Institute of Standards and Technology (NIST), Gaithersburg, MD, United States;Science and Technology Team, Pharma Services Group, Thermo Fisher Scientific, San Diego, CA, United States;

关键词: cell processing;    biomanufacturing;    cell count;    viability;    cell therapy;    gene therapy;    NIST;    ISO;   

DOI  :  10.3389/fbioe.2023.1223227

 received in 2023-05-15, accepted in 2023-07-20,  发布年份 2023

来源: Frontiers

【 摘 要 】

Cell counting is a fundamental measurement for determining viable cell numbers in biomanufacturing processes. The properties of different cell types and the range of intended uses for cell counts within a biomanufacturing process can lead to challenges in identifying suitable counting methods for each potential application. This is further amplified by user subjectivity in identifying the cells of interest and further identifying viable cells. Replacement of traditionally used manual counting methods with automated systems has alleviated some of these issues. However, a single cell type can exhibit different physical properties at various stages of cell processing which is further compounded by process impurities such as cell debris or magnetic beads. These factors make it challenging to develop a robust cell counting method that offers a high level of confidence in the results. Several initiatives from standards development organizations have attempted to address this critical need for standardization in cell counting. This study utilizes flow-based and image-based methods for the quantitative measurement of cell concentration and viability in the absence of a reference material, based on the tools and guidance provided by the International of Standards (ISO) and the US National Institute of Standards and Technology (NIST). Primary cells were examined at different stages of cell processing in a cell therapy workflow. Results from this study define a systematic approach that enables the identification of counting methods and parameters that are best suited for specific cell types and workflows to ensure accuracy and consistency. Cell counting is a foundational method used extensively along various steps of cell and gene therapy. The standard used in this study may be applied to other cell and gene therapy processes to enable accurate measurement of parameters required to guide critical decisions throughout the development and production process. Using a framework that confirms the suitability of the cell counting method used can minimize variability in the process and final product.

【 授权许可】

Unknown   
Copyright © 2023 Richards, Sarkar, Kandell, Snyder and Lakshmipathy.